Description

Continuity Logic Frontline Live for Healthcare

Innovation in Business Continuity Management

[tabs style=”default”] [tab title=”Executive Summary”] In today’s healthcare environment, ignoring an integrated view of business continuity in context of broader GRC results in processes, partners, employees, and systems that behave like leaves blowing in the wind. Healthcare organizations require a new paradigm for tackling business continuity, operational governance, risk management, and compliance in an integrated and harmonized process and architecture. Best practices require that healthcare organizations approach these areas as related integrated processes. Continuity Logic’s Frontline Live for Healthcare is a GRC solution that GRC 20/20 has researched, evaluated, and reviewed with a healthcare organization that is using it to support continuity and disaster situations in a highly demanding and critical infrastructure environment.   GRC 20/20 has evaluated and verified the innovation in business continuity found in Frontline Live for Healthcare and sees this as a compelling offering that has been built out to meet the specific requirements of a demanding healthcare environment, particularly in the face of chaos and disaster.  It delivers an intuitive and engaging user experience with depth of technical features that makes healthcare organizations more efficient, effective, and agile. In this context, GRC 20/20 has recognized Continuity Logic’s Frontline Live for Healthcare with a 2015 GRC Innovation Award for innovation in Business Continuity Management in 2015.

[/tab] [tab title=”Table of Contents”]

1. Healthcare Burdened by Disruption and Change
   • Healthcare Continuity: Symptoms and Diagnosis
   • Preventative Medicine: Integrated Business Continuity & GRC
2. Continuity Logic Frontline Live for Healthcare
   • Innovation in Business Continuity Management
   • What the Frontline Live for Healthcare Innovation Is About
   • How is the Frontline Live for Healthcare Innovation Different?
   • Benefits of Frontline Live for Healthcare
   • Considerations in Context of Frontline Live for Healthcare
3. About GRC 20/20 Research, LLC
4. Research Methodology

[/tab] [tab title=”Author”] Michael Rasmussen – The GRC Pundit @ GRC 20/20 Research, Michael Rasmussen is an internationally recognized pundit on governance, risk management, and compliance (GRC) – with specific expertise on the topics of GRC strategy, process, information, and technology architectures and solutions. With 23+ years of experience, Michael helps organizations improve GRC processes, design and implement GRC architectures, and select solutions that are effective, efficient, and agile. He is a sought-after keynote speaker, author, and advisor and is noted as the “Father of GRC” — being the first to define and model the GRC market in February 2002 while at Forrester Research, Inc. [/tab] [/tabs]

---

©GRC 20/20 Research, LLC. All Rights Reserved. No part of this publication may be reproduced, adapted, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of GRC 20/20 Research, LLC. If you are authorized to access this publication, your use of it is subject to the Usage Guidelines established in client contract. The information contained in this publication is believed to be accurate and has been obtained from sources believed to be reliable but cannot be guaranteed and is subject to change. GRC 20/20 accepts no liability whatever for actions taken based on information that may subsequently prove to be incorrect or errors in analysis. This research contains opinions of GRC 20/20 analysts and should not be construed as statements of fact.  GRC 20/20 disclaims all warranties as to the accuracy, completeness or adequacy of such information and shall have no liability for errors, omissions or inadequacies in such information.  Although GRC 20/20 may include a discussion of related legal issues, GRC 20/20 does not provide legal advice or services and its research should not be construed or used as such.